TDGF1 Antikörper (N-Term)
Kurzübersicht für TDGF1 Antikörper (N-Term) (ABIN363493)
Target
Alle TDGF1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Reacts with mouse ~18 kDa (core form) and ~36 kDa (glycosylated/ post-transcriptionally modified form) TDGF1 protein
-
Kreuzreaktivität (Details)
- May cross reacts with human protein. (78 % sequence homology).
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Synthetic peptide made to an N-terminal portion of the murine cripto protein sequence
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- WB : 1/500 to 1/2 000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C. Do not freeze.
-
-
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
-
Andere Bezeichnung
- Teratocarcinoma-Derived Growth Factor 1
-
Pathways
- EGFR Signaling Pathway
Target
-